# Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

> **NCT00433069** · PHASE2 · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 5 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Interferon Alfa-2a
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00433069
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-12
- **Final completion:** 2008-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00433069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00433069, "Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00433069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*